Second line therapy in type 2 diabetes: legacy effect activation
Type 2 diabetes causes hundred thousand deaths worldwide every year. Though new antidiabetic drugs appear annually and new classes of drugs are invented approximately every ten years still a lot of type 2 diabetic patients remain to be out of the target glycemic levels. According to most of the gui...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Language: | EN RU |
| Published: |
Endocrinology Research Centre
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/effa23afa59d45be871c37adb10145d3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|